Digital Innovation Index
This annual index reveals how the top companies are leveraging digital advancements to accelerate development, improve patient engagement, and drive impactful change in healthcare.
2025 Digital Innovation Index
The 2025 results launched on the 4th of November live at the CNS Summit in Boston.
-
- Roche 0
- 2024 1st
- 2023 2nd
- 1
- AstraZeneca 0
- 2024 2nd
- 2023 1st
- 2
- Sanofi 4
- 2024 7th
- 2023 6th
- 3
- Pfizer 2
- 2024 6th
- 2023 4th
- 4
- Bayer 1
- 2024 4th
- 2023 8th
- 5
- Novartis 9
- 2024 15th
- 2023 17th
- 6
- Takeda 6
- 2024 13th
- 2023 13th
- 7
- Bristol-Myers Squibb 5
- 2024 3rd
- 2023 10th
- 8
- Johnson & Johnson 0
- 2024 9th
- 2023 15th
- 9
- Eli Lilly 2
- 2024 12th
- 2023 7th
- 10
- Roche 0
Download the report
IDEA Pharma’s Digital Pharma Invention Index, and the accompanying White Paper, explore the performance of individual companies in much greater detail. By accessing our White Papers, you are given an inside look into our research and findings.
- 1 Methodology and analysis
- 2 Extended profiles of the Top 10 overall companies
- 3 The report in full
- 4 Ranking of performance in: Commercial, Clinical & Research
Have an opinion?
We’d love to hear your thoughts. We are open to further discussion and encourage questions and comments about our rankings. Please give us a shout to continue the conversation, we are here to answer.
